Italy vs Switzerland: Previously treated cases tested for RR-/MDR-TB
Italy
36.0%
in 2024
Switzerland
48.0%
in 2024
Italy rank
156th
Switzerland rank
153rd
Previously treated cases tested for RR-/MDR-TB over time
- Italy
- Switzerland
How they compare
Switzerland currently reports 48.0% against 36.0% in Italy, a difference of 12.0%.
That makes Switzerland's figure about 1.3 times Italy's.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Switzerland ahead.
Italy ranks 156th and Switzerland ranks 153rd of 180 countries.
Across the 3 decades both report, Italy averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Italy | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.1% | 69.0% | 21.9% | Switzerland |
| 2010s | 75.7% | 63.8% | 11.9% | Italy |
| 2020s | 23.8% | 36.6% | 12.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Italy or Switzerland?
- Switzerland, at 48.0% against 36.0% in Italy as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Italy and Switzerland?
- 12.0%, with Switzerland ahead.
- How many years of comparable data are there for Italy and Switzerland?
- 18 years are reported by both, from 2005 to 2024.
- How do Italy and Switzerland rank globally for previously treated cases tested for rr-/mdr-tb?
- Italy ranks 156th and Switzerland ranks 153rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.